+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Uterine Cancer Drugs Market Research Reports

Uterine Cancer Therapeutics and Diagnostics: Global Strategic Business Report - Product Thumbnail Image

Uterine Cancer Therapeutics and Diagnostics: Global Strategic Business Report

  • Report
  • September 2023
  • 173 Pages
  • Global
From
Endometrial Cancer Treatment Global Market Report 2023 - Product Thumbnail Image

Endometrial Cancer Treatment Global Market Report 2023

  • Report
  • August 2023
  • 175 Pages
  • Global
From
Global Uterine Cancer Therapeutics & Diagnostics Market by Cancer Type, Product - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030 - Product Thumbnail Image

Global Uterine Cancer Therapeutics & Diagnostics Market by Cancer Type, Product - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030

  • Report
  • July 2023
  • 198 Pages
  • Global
From
Endometrial Cancer Treatment: Global Strategic Business Report - Product Thumbnail Image

Endometrial Cancer Treatment: Global Strategic Business Report

  • Report
  • September 2023
  • 192 Pages
  • Global
From
Endometrial Cancer Market - Growth, Trends, and Forecasts (2023 - 2028) - Product Thumbnail Image

Endometrial Cancer Market - Growth, Trends, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 112 Pages
  • Global
From
JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

JEMPERLI (dostarlimab) Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Global Uterine Cancer Therapeutics & Diagnostics Market (2023-2028) by Product, Cancer Type, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis - Product Thumbnail Image

Global Uterine Cancer Therapeutics & Diagnostics Market (2023-2028) by Product, Cancer Type, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis

  • Report
  • April 2023
  • 187 Pages
  • Global
From
Global Uterine Cancer Drugs Market (2023-2028) by Type, Mechanism of Action, Drugs, Therapy & Treatment, Route of Administration, Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis - Product Thumbnail Image

Global Uterine Cancer Drugs Market (2023-2028) by Type, Mechanism of Action, Drugs, Therapy & Treatment, Route of Administration, Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis

  • Report
  • April 2023
  • 146 Pages
  • Global
From
Global Cyclophosphamide Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Cyclophosphamide Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
CAS 302-23-8 Hydroxyprogesterone acetate Chemical World Database - Product Thumbnail Image

CAS 302-23-8 Hydroxyprogesterone acetate Chemical World Database

  • Database
  • September 2023
  • Global
Asia-Pacific Uterine Cancer Therapeutics & Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025) - Product Thumbnail Image

Asia-Pacific Uterine Cancer Therapeutics & Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)

  • Report
  • June 2020
  • 68 Pages
  • Asia Pacific
From
Uterine Cancer Therapeutics & Diagnostics Market - Growth, Trends, & Forecasts (2020-2025) - Product Thumbnail Image

Uterine Cancer Therapeutics & Diagnostics Market - Growth, Trends, & Forecasts (2020-2025)

  • Report
  • May 2020
  • 117 Pages
  • Global
From
Endometrial Cancer - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Endometrial Cancer - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Endometrial Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

Endometrial Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Advanced Endometrial Cancer - Pipeline Insight, 2021 - Product Thumbnail Image

Advanced Endometrial Cancer - Pipeline Insight, 2021

  • Drug Pipelines
  • September 2021
  • 60 Pages
  • Global
From
Endometrial Cancer - Pipeline Insight, 2021 - Product Thumbnail Image

Endometrial Cancer - Pipeline Insight, 2021

  • Clinical Trials
  • March 2021
  • 60 Pages
  • Global
From
Research Report on China's Anastrozole Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Anastrozole Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
Middle East & Africa Uterine Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Middle East & Africa Uterine Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • January 2022
  • 68 Pages
  • Middle East, Africa
From
Global Uterine Cancer Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Uterine Cancer Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Anastrozole Tablets Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027 - Product Thumbnail Image

Anastrozole Tablets Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • Report
  • May 2020
  • Global
From
Loading Indicator

Uterine Cancer Drugs are medications used to treat cancer of the uterus. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and reduce the risk of recurrence. Commonly used drugs include chemotherapy, hormone therapy, targeted therapy, and immunotherapy. Chemotherapy drugs are used to kill cancer cells, while hormone therapy drugs are used to block the hormones that can cause cancer cells to grow. Targeted therapy drugs are used to target specific cancer cells, while immunotherapy drugs are used to boost the body's immune system to fight cancer. Some of the major companies in the Uterine Cancer Drugs market include Pfizer, Merck, Novartis, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and production of drugs for the treatment of uterine cancer. Show Less Read more